We are live on ! Find out more
LG

LaFleur & Godfrey Portfolio holdings

AUM $842M Turnover 10.46%
1-Year Est. Return 24.12%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+24.12%
3 Year Est. Return
+85.19%
5 Year Est. Return
+109.34%
10 Year Est. Return
+386.09%
AUM
$415M
AUM Growth
+$14.9M
Cap. Flow
-$7.04M
Cap. Flow %
-1.7%
Top 10 Hldgs %
42.67%
Holding
62
New
2
Increased
16
Reduced
40
Closed
–
Avg Time Held
4 years
Top 10 Avg Time Held
2.6 years
Top 20 Avg Time Held
2.9 years

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$2.01M
2
TFC icon
Truist Financial
TFC
+$959K
3
VMC icon
Vulcan Materials
VMC
+$746K
4
IPHS
Innophos Holdings, Inc.
IPHS
+$729K
5
ABBV icon
AbbVie
ABBV
+$495K

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$3.06M
2
HOLX icon
Hologic
HOLX
+$2.41M
3
CPRT icon
Copart
CPRT
+$817K
4
MSFT icon
Microsoft
MSFT
+$763K
5
BA icon
Boeing
BA
+$732K

Sector Composition

Rank Sector Weight
1 Healthcare 27.9%
2 Technology 21.47%
3 Industrials 14.1%
4 Energy 9.35%
5 Financials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$5.01T
$23.9M 5.76%
423,444
-9,596
-2% -$500K
2013 Q2
21 quarters
INTC icon
2
Intel
INTC
$475B
$21.7M 5.23%
458,836
+4,494
+1% +$219K
2013 Q2
21 quarters
COP icon
3
ConocoPhillips
COP
$176B
$20.4M 4.91%
263,093
-6,335
-2% -$457K
2013 Q2
21 quarters
ECL icon
4
Ecolab
ECL
$81B
$19M 4.57%
120,939
-4,630
-4% -$686K
2013 Q2
21 quarters
JPM icon
5
JPMorgan Chase
JPM
$902B
$17.4M 4.18%
153,861
-705
-0.5% -$80K
2013 Q2
21 quarters
RTN
6
DELISTED
Raytheon Company
RTN
$17M 4.1%
82,246
-1,855
-2% -$369K
2013 Q2
21 quarters
SYK icon
7
Stryker
SYK
$113B
$16M 3.84%
89,771
-3,145
-3% -$537K
2013 Q2
21 quarters
MRK icon
8
Merck
MRK
$360B
$15M 3.6%
220,933
-3,210
-1% -$205K
2015 Q3
12 quarters
CSCO icon
9
Cisco
CSCO
$423B
$14.2M 3.42%
292,146
-1,143
-0.4% -$51.4K
2013 Q2
21 quarters
APA icon
10
APA Corp
APA
$17.2B
$12.7M 3.06%
266,607
-5,783
-2% -$260K
2013 Q2
21 quarters
VAR
11
DELISTED
Varian Medical Systems, Inc.
VAR
$12.6M 3.04%
112,604
-1,625
-1% -$184K
2013 Q2
21 quarters
JNJ icon
12
Johnson & Johnson
JNJ
$616B
$12.3M 2.95%
88,679
+265
+0.3% +$35.2K
2013 Q2
21 quarters
PAYX icon
13
Paychex
PAYX
$39.7B
$11.9M 2.86%
161,295
-4,983
-3% -$358K
2013 Q2
21 quarters
BA icon
14
Boeing
BA
$150B
$11.7M 2.81%
31,334
-2,083
-6% -$732K
2016 Q1
10 quarters
ABBV icon
15
AbbVie
ABBV
$504B
$10.5M 2.53%
110,893
+5,220
+5% +$495K
2013 Q2
21 quarters
GILD icon
16
Gilead Sciences
GILD
$194B
$10.2M 2.46%
132,494
+26,626
+25% +$2.01M
2017 Q4
3 quarters
VMC icon
17
Vulcan Materials
VMC
$33.4B
$9.9M 2.39%
89,310
+6,430
+8% +$746K
2016 Q4
7 quarters
CPRT icon
18
Copart
CPRT
$25.8B
$9.28M 2.24%
720,180
-54,720
-7% -$817K
2013 Q2
21 quarters
TMO icon
19
Thermo Fisher Scientific
TMO
$255B
$8.92M 2.15%
36,557
+600
+2% +$138K
2018 Q1
2 quarters
TFC icon
20
Truist Financial
TFC
$57.5B
$8.91M 2.15%
183,551
+18,682
+11% +$959K
2015 Q3
12 quarters
MSFT icon
21
Microsoft
MSFT
$3.93T
$8.71M 2.1%
76,151
-7,040
-8% -$763K
2013 Q2
21 quarters
WWD icon
22
Woodward
WWD
$19.4B
$7.94M 1.91%
98,234
-920
-0.9% -$73.9K
2013 Q2
21 quarters
NTNX icon
23
Nutanix
NTNX
$18.1B
$7.9M 1.9%
184,905
+4,290
+2% +$226K
2017 Q2
5 quarters
RMD icon
24
ResMed
RMD
$33.6B
$7.4M 1.78%
64,120
-430
-0.7% -$47.1K
2013 Q2
21 quarters
GNTX icon
25
Gentex
GNTX
$4.43B
$6.97M 1.68%
324,965
-7,491
-2% -$173K
2013 Q2
21 quarters
1
2 3

Similar funds

EBSAM
Eubel Brady & Suttman Asset Management Miamisburg, Ohio $842M AUM 17.25% 1-Year Est. Return
KM
Kora Management Brooklyn, New York $843M AUM 11.3% 1-Year Est. Return
PCOC
Power Corp of Canada Montreal, Quebec, Canada $843M AUM 39.5% 1-Year Est. Return
PMWMG
Parr McKnight Wealth Management Group Minneapolis, Minnesota $844M AUM 18.11% 1-Year Est. Return
RA
Range Advisory Mclean, Virginia $840M AUM
AGA
Arkos Global Advisors Houston, Texas $844M AUM 16.51% 1-Year Est. Return
SNB
Security National Bank Omaha, Nebraska $838M AUM 39.07% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

LaFleur & Godfrey's Q3 2018 Portfolio in Review

As of Q3 2018, LaFleur & Godfrey held 62 positions worth $415M, up 3.7% from $400M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 3.2%. LaFleur & Godfrey opened 2 new positions and made no exits, leaving the 62-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Technology and Industrials.

  • LaFleur & Godfrey's largest Q3 2018 buy was Innophos Holdings, Inc.: 15,940 shares worth $708K.
  • LaFleur & Godfrey added most to Gilead Sciences in Q3 2018, an estimated $2.01M increase.
  • LaFleur & Godfrey's biggest Q3 2018 reduction was AT&T, cutting an estimated $3.06M.
  • LaFleur & Godfrey's ten largest holdings make up 43% of its $415M portfolio in Q3 2018.
  • LaFleur & Godfrey opened 2 new positions and closed 0 in Q3 2018.
  • LaFleur & Godfrey's portfolio value rose 3.7% quarter-over-quarter to $415M.

Based on LaFleur & Godfrey's 13F filing for Q3 2018, filed 13 Dec 2018.